Anyone who knows someone on Ozempic or Mounjaro knows the weekly routine of taking a pen out of the refrigerator and pushing a needle into the stomach, and most other peptides still reach people the same way. The Precision Peptide Company (CSE: $BPC) (OTCQB: $PNGAF) is replacing that routine with peptide patches that stick to the skin like a bandage and deliver a measured dose without a syringe or a refrigerator. PNGAF has four of those patches in its line with the first alre

Med Holdings Group ( OTCID : $YUKA ) just put out its first press release in almost a year, and what's in it looks like the early stages of a playbook that has already produced billion-dollar outcomes in this sector. The company is building a hybrid model that combines a national telehealth platform with brick-and-mortar urology and men's health clinics across Florida, the fastest-growing large state in the country and one of the oldest demographically. Hims and Hers (NYSE: